期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Medicine and Data. 2022; 6: (6) ; 185-187 ; DOI: 10.12208/j.ijmd.20220273.

Clinical Observation on Xuesaitong Injection in Treating Senile Cardiovascularand Cerebrovascular Diseases
血塞通注射液治疗老年性心脑血管疾病的临床观察

作者: 冯尚*,

桐柏县中心医院神经内科 河南南阳

*通讯作者: 冯尚,单位:桐柏县中心医院神经内科 河南南阳;

发布时间: 2022-11-21 总浏览量: 39

摘要

目的 探讨临床治疗老年心脑脑血管疾病过程中血塞通注射液的应用效果。方法 选择2022年收治的80例老年心脑血管患者开展研究,根据治疗方案的不同将两组患者均分为对照组及观察组,每组患者40例。以香丹注射液对对照组患者进行干预治疗,观察组患者则采取血塞通注射液进行干预,对两组患者治疗情况进行对比。结果 两组患者在治疗前病情无明显差异,P>0.05。注射治疗积极改善了两组患者的血流流变学指证,且与对照组相比较,观察组指证改善状况更加显著,P<0.05。在治疗总有效率方面相比较,观察组织患者整体治疗效率明显超过对照组,差异显著,P<0.05。结论 在临床治疗老年性心血管疾病的过程中血塞通注射液有效吸收患者血管中的血肿,从而避免对于神经系统造成较大损伤,具有良好的临床应用效果。

关键词: 血塞通;老年性心脑血管疾病;疗效

Abstract

Objective To investigate the effect of Xuesaitong injection in the clinical treatment of senile cardio cerebral vascular diseases.
Methods 80 elderly patients with cardiovascular and cerebrovascular diseases admitted in 2022 were randomly divided into control group and observation group, with 40 patients in each group. Xiangdan injection was used to intervene the patients in the control group, and Xuesaitong injection was used to intervene the patients in the observation group.
Results There was no significant difference between the two groups before treatment (P>0.05). The injection treatment actively improved the hemorheology indications of the patients in the two groups, and compared with the control group, the improvement of the indications in the observation group was more significant (P<0.05). Compared with the control group in terms of the total effective rate of treatment, the overall therapeutic efficiency of the tissue patients was significantly higher than that of the control group, with a significant difference (P<0.05).
Conclusion   Xuesaitong injection can effectively absorb the hematoma in the blood vessels of patients in the course of clinical treatment of senile cardiovascular diseases, so as to avoid causing greater damage to the nervous system. It has a good clinical application effect.

Key words: Xuesaitong; Senile cardiovascular and cerebrovascular diseases; curative effect

参考文献 References

[1] 黄燕莉,张冯佐,袁小敏,栾欣,董哲,盖云,杨晓萍.注射用血塞通(冻干)对老年急性缺血性脑卒中的疗效及安全性评价[J].中国民间疗法,2022,30(17):93-96.

[2] 张军伟,许俊华.倍他司汀联合血塞通对后循环缺血性眩晕患者血液流变学、椎-基底动脉血流动力学及生化指标的影响[J].辽宁医学杂志,2022,36(04):29-31.

[3] 邱文然. 基于混合方法的血塞通软胶囊干预脑梗死的临床应用特征与共识研究[D].中国中医科学院,2022.

[4] 唐洁. 探讨血塞通注射液对MCAO大鼠静脉溶栓后血清ET-1、VEGF水平的影响[D].湖南中医药大学,2022.

[5] 李千.探讨血塞通联合依达拉奉对脑梗死恢复期患者脑循环动力学、神经功能及生活质量影响的研究[J].北方药学,2022,19(04):151-153+160.

[6] 张彩平,彭昱东,吴红军.血塞通对心绞痛患者介入治疗后血清同型半胱氨酸等的影响[J].西北药学杂志,2022,37(02):154-158.

引用本文

冯尚, 血塞通注射液治疗老年性心脑血管疾病的临床观察[J]. 国际医学与数据杂志, 2022; 6: (6) : 185-187.